Comparison of cardiomyogenic potential among human ESC and iPSC lines

Cell Transplantation

Volumn 21, Issue 11, 2012, Pages 2523-2530

  Sepac, Ana ^a   Si Tayeb, Karim ^a   Sedlic, Filip ^a   Barrett, Sara ^a   Canfield, Scott ^a   Duncan, Stephen A ^a   Bosnjak, Zeljko J ^a   Lough, John W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Directed cardiac differentiation; Human embryonic stem cells (hESCs); Human induced pluripotent stem cells (hiPSCs); qPCR

Indexed keywords

ISL1 PROTEIN; MESP1 PROTEIN; PROTEIN; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION;

CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC;

EID: 84871578911     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X653165     Document Type: Article

References (18)

1. Carvajal-Vergara, X.; Sevilla, A.; D'Souza, S. L.; Ang, Y. S.; Schaniel, C.; Lee, D. F.; Yang, L.; Kaplan, A. D.; Adler, E. D.; Rozov, R.; Ge, Y.; Cohen, N.; Edelmann, L. J.; Chang, B.; Waghray, A.; Su, J.; Lichtenbelt, K. D.; Tartaglia, M.; Gelb, B.D.; Lemischka, I. R. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465(7299):808-812; 2010.
2. Kattman, S. J.; Witty, A. D.; Gagliardi, M.; Dubois, N. C.; Niapour, M.; Hotta, A.; Ellis, J.; Keller, G. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8(2):228-240; 2011.
3. Laflamme, M. A.; Chen, K. Y.; Naumova, A. V.; Muskheli, V.; Fugate, J. A.; Dupras, S. K.; Reinecke, H.; Xu, C.; Hassanipour, M.; Police, S.; O'Sullivan, C.; Collins, L; Chen, Y.; Minami, E.; Gill, E. A.; Ueno, S.; Yuan, C.; Gold, J.; Murry, C. E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25(9):1015-1024; 2007.
4. Martinez-Fernandez, A.; Nelson, T. J.; Yamada, S.; Reyes, S.; Alekseev, A. E.; Perez-Terzic, C.; Ikeda, Y.; Terzic, A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ. Res. 105(7):648-656; 2009.
5. Mauritz, C.; Schwanke, K.; Reppel, M.; Neef, S.; Katsirntaki, K.; Maier, L. S.; Nguemo, F.; Menke, S.; Haustein, M.; Hescheler, J.; Hasenfuss, G.; Martin, U. Generation of functional murine cardiac myocytes from induced pluri potent stem cells. Circulation 118(5):507-517; 2008.
6. Moore, J. C.; Fu, J.; Chan, Y. C.; Lin, D.; Tran, H.; Tse, H. F.; Li, R. A. Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem. Biophys. Res. Commun. 372(4):553-558; 2008.
7. Narazaki, G.; Uosaki, H.; Teranishi, M.; Okita, K.; Kim, B.; Matsuoka, S.; Yamanaka, S.; Yamashita, J. K. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118(5):498-506; 2008.
8. Osafune, K.; Caron, L.; Borowiak, M.; Martinez, R. J.; Fitz-Gerald, C. S.; Sato, Y.; Cowan, C. A.; Chien, K. R.; Melton, D. A. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26(3):313-315; 2008.
9. Rudy-Reil, D.; Lough, J. Avian precardiac endoderm/ mesoderm induces cardiac myocyte differentiation in murine embryonic stem cells. Circ. Res. 94(12):e107-116; 2004.
10. Schenke-Layland, K.; Rhodes, K. E.; Angelis, E.; Butylkova, Y.; Heydarkhan-Hagvall, S.; Gekas, C.; Zhang, R.; Goldhaber, J. I.; Mikkola, H. K.; Plath, K.; Maclellan, W. R. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 26(6):1537-1546; 2008.
11. Sepac, A.; Sedlic, F.; Si-Tayeb, K.; Lough, J.; Duncan, S. A.; Bienengraeber, M.; Park, F.; Kim, J.; Bosnjak, Z. J. Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells. Anesthesiology 113(4):906-916; 2010.
12. Si-Tayeb, K.; Noto, F. K.; Nagaoka, M.; Li, J.; Battle, M. A.; Duris, C.; North, P. E.; Dalton, S.; Duncan, S. A. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51(1):297-305; 2010.
13. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluri-potent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872; 2007.
14. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145-1147; 1998.
15. Yu, J.; Vodyanik, M. A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J. L.; Tian, S.; Nie, J.; Jonsdottir, G. A.; Ruotti, V.; Stewart, R.; Sluvkin, I. I.; Thomson, J. A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917-1920; 2007.
16. Zhang, J.; Wilson, G. F.; Soerens, A. G.; Koonce, C. H.; Yu, J.; Palecek, S. P.; Thomson, J. A.; Kamp, T. J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104(4):e30-e41; 2009.
17. Zhao, M.; Barron, M. R.; Li, Z.; Koprowski, S.; Hall, C. L.; Lough, J. Making stem cells infarct avid. Cell Transplant. 19(2):245-250; 2010.
18. Zwi, L.; Caspi, O.; Arbel, G.; Huber, I.; Gepstein, A.; Park, I. H.; Gepstein, L. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120(15):1513-1523; 2009.